[{"Assets_0_Q3_USD":422642000.0,"CIK":"1706431","CommonStockSharesConverted_0_Q3_shares":11728232.0,"CommonStockSharesOutstanding_0_Q3_shares":11728232.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":-4.6,"EarningsPerShareBasic_3_Q3_USD":-11.53,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"3076942595.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-90747000.0,"NetIncomeLossConverted_1_Q3_USD":-48314000.0,"NetIncomeLossConverted_3_Q3_USD":-110912000.0,"OfficialName":"Vir Biotechnology Inc. Common Stock","RevenuesConverted_1_Q3_USD":1403000.0,"RevenuesConverted_3_Q3_USD":7111000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q3_USD":-280797000.0,"Ticker":"VIR","filed":"20191119","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2019.0","name":"VIR BIOTECHNOLOGY, INC.","period":"20190930","qtrs":"0","uom":"USD"}]